Patient Knowledge of Safe Use of ER/LA Opioid Analgesics Following Implementation of the Class-Wide REMS: A Survey Study

BACKGROUND/RATIONALE: The US Food and Drug Administration (FDA) approved a Risk Evaluation and Mitigation Strategy (REMS) for extended release/long-acting (ER/LA) opioids in 2012. The purpose of this study was to assess patient knowledge of the safe use of these products following implementation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Daina B, Desai, Vibha C A, Stephenson, Judith J, Cepeda, M Soledad, Lyons, Jennifer G, Holick, Crystal N, Wedin, Gregory P, Lanes, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917306/
https://www.ncbi.nlm.nih.gov/pubmed/33658767
http://dx.doi.org/10.2147/PPA.S286935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917306/
https://www.ncbi.nlm.nih.gov/pubmed/33658767
http://dx.doi.org/10.2147/PPA.S286935

Ejemplares similares